Sarcoidosis Clinical Trials

50 recruitingLast updated: June 18, 2026

There are 50 actively recruiting sarcoidosis clinical trials across 21 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3. Top locations include Philadelphia, Pennsylvania, United States, Paris, France, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Sarcoidosis Trials at a Glance

50 actively recruiting trials for sarcoidosis are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Philadelphia, Paris, and Baltimore. Lead sponsors running sarcoidosis studies include Assistance Publique - Hôpitaux de Paris, Duke University, and Mayo Clinic.

Browse sarcoidosis trials by phase

Treatments under study

About Sarcoidosis Clinical Trials

Looking for clinical trials for Sarcoidosis? There are currently 27 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Sarcoidosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Sarcoidosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 50 trials

Recruiting

Role of Genetic Factors in the Development of Lung Disease

AsthmaCystic FibrosisPulmonary Fibrosis+2 more
National Heart, Lung, and Blood Institute (NHLBI)3,500 enrolled2 locationsNCT00001532
Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

SarcoidosisIdiopathic Pulmonary FibrosisInterstitial Lung Diseases+1 more
University of Chicago4,000 enrolled1 locationNCT00470327
Recruiting

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

PericarditisRheumatoid ArthritisSarcoidosis+10 more
Assistance Publique - Hôpitaux de Paris5,000 enrolled1 locationNCT07077304
Recruiting
Phase 1Phase 2

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Pulmonary Sarcoidosis
Xentria, Inc.94 enrolled34 locationsNCT05890729
Recruiting
Phase 2

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Myocarditis Due to DrugCardiac SarcoidosisAcute Cellular Graft Rejection
John O. Prior69 enrolled1 locationNCT05499637
Recruiting
Phase 3

Cardiac Sarcoidosis Randomized Trial

SarcoidosisCardiac Sarcoidosis
Ottawa Heart Institute Research Corporation194 enrolled30 locationsNCT03593759
Recruiting
Not Applicable

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

Suspected Sarcoidosis
University Health Network, Toronto128 enrolled1 locationNCT06220526
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesSarcoidosis+14 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting
Not Applicable

Virtual Patient Groups for Sarcoidosis Associated Fatigue

DepressionFatigueAnxiety+2 more
The Cleveland Clinic100 enrolled1 locationNCT07073963
Recruiting
Phase 1Phase 2

Feasibility of Semaglutide in Advanced Lung Disease

ObesityChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+2 more
University of Pennsylvania8 enrolled1 locationNCT05746039
Recruiting
Phase 2

Repurposing Tilmanocept for Cardiac Sarcoidosis

Cardiac Sarcoidosis
Duke University15 enrolled1 locationNCT07159074
Recruiting
Not Applicable

Corticosteroid Tapering in Sarcoidosis

Sarcoidosis
Royal Brompton & Harefield NHS Foundation Trust100 enrolled1 locationNCT07498842
Recruiting

Immunological Mechanisms in Sarcoidosis

Sarcoidosis
Region Stockholm5,000 enrolled1 locationNCT06576505
Recruiting

MoMa Signature During Granulomatosis

SarcoidosisTuberculosis
Assistance Publique - Hôpitaux de Paris100 enrolled1 locationNCT05916638
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Phase 3

Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis

Sarcoidosis
Assistance Publique - Hôpitaux de Paris90 enrolled1 locationNCT05689879
Recruiting
Not Applicable

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Lung Cancer (Diagnosis)Chronic Obstructive Pulmonary DiseaseSarcoidosis+2 more
Université Catholique de Louvain425 enrolled1 locationNCT07384897
Recruiting

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

Noonan SyndromeFabry DiseaseCardiac Amyloidosis+4 more
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07336394
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

Institutional Registry of Rare Diseases

ParagangliomaPheochromocytomaAmyloidosis+23 more
Hospital Italiano de Buenos Aires380 enrolled1 locationNCT06573723